Truist Securities Maintains Hold on Pediatrix Medical Group, Raises Price Target to $28
Benzinga Newsdesk 3 months ago
Analyst RatingsNewsPrice Target
Truist Securities analyst David Macdonald maintains Pediatrix Medical Group (NYSE:MD) with a Hold and raises the price target from $23 to $28.
Truist Securities analyst David Macdonald maintains Pediatrix Medical Group (NYSE:MD) with a Hold and raises the price target from $23 to $28.